Revolutionizing Breast Cancer Treatment: Innovative Drug Trials and Collaborations Target Aggressive Forms of the Disease |Dr. Quay , CEO, Atossa Therapeutics Inc. 00:10:00
This overview highlights Atossa Therapeutics' CEO discussing ongoing clinical trials of their innovative drug, oral Endoxifen, targeting various stages of breast cancer management, including prevention and neoadjuvant treatment, alongside research collaborations aimed at transforming aggressive forms of the disease.